Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-29 @ 3:05 PM
Study NCT ID:
NCT01292460
Status:
COMPLETED
Last Update Posted:
2013-03-13
First Post:
2011-02-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies
Sponsor:
Santen Oy
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
201050
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None